| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,770 |
12,187 |
$600K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,702 |
1,470 |
$75K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
701 |
647 |
$35K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,097 |
1,833 |
$23K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,144 |
920 |
$12K |
| 87501 |
|
338 |
291 |
$5K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
68 |
62 |
$4K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
113 |
110 |
$4K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
152 |
144 |
$3K |
| 87807 |
|
49 |
40 |
$299.09 |
| 81002 |
|
87 |
79 |
$192.79 |